New Publication: Clinical Trials and Biomedical Research in India
Posted by By nishithadmin at 2 September, at 15 : 37 PM Print
Warning: count(): Parameter must be an array or an object that implements Countable in /web/qlc/nishith.tv/htdocs/wp-content/themes/Video/single_blog.php on line 46
Warning: count(): Parameter must be an array or an object that implements Countable in /web/qlc/nishith.tv/htdocs/wp-content/themes/Video/single_blog.php on line 52
Legal and Regulatory Framework
Clinical trials in India has been a buzzing topic in the pharmaceutical industry for decades. In the past few years, the industry has witnessed a growing interest from foreign players seeking to conduct clinical trials in India to cater to global demands. The industry is striding ahead by digitization and adoption of technology which has led to the standardisation and automation of processes. In this paper, the authors have discussed the law pertaining to clinical trials in India, the approval procedures and emerging trends and developments in the industry.
Please click here to access our paper.
Regards,
Tanya Kukade, Varsha Rajesh, Eshika Phadke and Dr. Milind Antani
For any help or assistance, please email us on concierge@nishithdesai.com.
Do visit us at www.nishithdesai.com.
Disclaimer
The contents of this hotline should not be construed as legal opinion. View detailed disclaimer.
This hotline does not constitute a legal opinion and may contain information generated using various artificial intelligence (AI) tools or assistants, including but not limited to our in-house tool, NaiDA. We strive to ensure the highest quality and accuracy of our content and services. Nishith Desai Associates is committed to the responsible use of AI tools, maintaining client confidentiality, and adhering to strict data protection policies to safeguard your information.
This hotline provides general information existing at the time of preparation. The Hotline is intended as a news update and Nishith Desai Associates neither assumes nor accepts any responsibility for any loss arising to any person acting or refraining from acting as a result of any material contained in this Hotline. It is recommended that professional advice be taken based on the specific facts and circumstances. This hotline does not substitute the need to refer to the original pronouncements.
This is not a spam email. You have received this email because you have either requested for it or someone must have suggested your name. Since India has no anti-spamming law, we refer to the US directive, which states that a email cannot be considered spam if it contains the sender’s contact information, which this email does. In case this email doesn’t concern you, please unsubscribe from mailing list.
